• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Compliance: Transforming a Necessity Iinto the Ultimate Partnership Leveraging modern technology, services, and expertise to optimize HCP engagement

Webcast

Webcasts

Now Available On Demand! HCP engagements remain the single-most valuable way to provide information needed by HCPs to effectively prescribe the best treatments for their patients. However, the complexities of managing these engagements are burdensome and complex. In this webinar, learn the keys to navigating this increasingly complex space while enabling optimized, worry-free engagements with exceptional HCP experiences.

Register Free: http://www.pharmexec.com/pe_w/compliance

Event overview:

HCP engagements remain the single-most valuable way to provide information needed by HCPs to effectively prescribe the best treatments for their patients. However, increased regulatory pressures, general behavioral changes driven by the pandemic, technology advancements, HCP preferences, and greater exclusivity have all placed additional challenges on an already complicated, burdensome, and inefficient space.

In this webinar, you will hear from IQVIA’s leading experts who will share their insights into the current state of the industry and the keys to navigating this increasingly complex space while enabling optimized, worry-free engagements with exceptional HCP experiences.

3 Key take-aways

  • Learn key industry trends and insights
  • Discover real-world best practices
  • Learn how to maximize end-to-end efficiencies that drive HCP satisfaction while addressing pain points of managing commercial compliance controls

Speakers

Bill Buzzeo
Vice President, US Compliance and Quality COE
IQVIA

Bill has 25+ years of experience in the areas of sales, operations, compliance, and leadership, including 20 years with IQVIA (through various acquisitions and mergers) and seven years with Knoll Pharmaceuticals. Currently, he leads the US compliance and quality business unit with a goal on expanding compliance and quality offerings across IQVIA’s vast customer base, with a focus on customer satisfaction, technology innovation, service excellence, and employee growth.

Justin Will
Sr. Principal, Commercial Compliance Consulting & Managed Services Global Compliance Consulting
IQVIA

As a Senior Principal with over 15 years of diverse life sciences industry and consulting experience, Justin oversees IQVIA’s global compliance consulting strategy and client delivery across the product portfolio, including compliance managed services engagements. With extensive experience developing, implementing, and leading strategic compliance programs for pharmaceutical, biotech, and medical device companies, he has particular interest in risk management, compliance, and operational excellence.

Thomas Hayes
Global Head of Offering Management for HCP Engagement Services
IQVIA

Tom is a Director of Global Offering Management for IQVIA Commercial Compliance. He leads the strategy and integrated roadmap for IQVIA’s HCP Engagement Services.Prior to his current role, Tom served as Director of Strategic Operations and Delivery Tech Principal for IQVIA Commercial Compliance.

Burja Atakan
Manager, Strategy Global Compliance Consulting
IQVIA

Burja manages and leads the prompt delivery and high-quality work of all IQVIA commercial compliance consulting engagements including process design and implementation, risk assessments, auditing and monitoring, fair market value analysis, technology transformation, and change management.

Register Free: http://www.pharmexec.com/pe_w/compliance

Related Content